Tag: Prescription Drugs
Short-Term PrEP Feasible for Men at Risk for HIV on Vacation
High levels of medication adherence observed; many interested in transitioning to long-term PrEP
Longer Bisphosphonate Use May Up Atypical Femur Fracture Risk
Rapid decline in atypical fracture risk seen when bisphosphonate discontinued in women ≥50 years
Evinacumab Cuts LDL-C Level in Familial Hypercholesterolemia
LDL-C down at week 24 with evinacumab versus placebo in homozygous familial hypercholesterolemia
CNS-Active Meds Often Prescribed for Older Adults With Dementia
Overall, Rx filled for antidepressants in 49.8 percent, opioids in 29.8 percent, anxiolytics in 26.8 percent
Bisphosphonates Safe but May Not Improve Bone Marrow Lesion Volume
However, a trend was seen toward a decrease in bone marrow lesion volume
Drug Combo Prolongs Survival in Acute Myeloid Leukemia
Findings seen for azacitidine + venetoclax in older patients ineligible for intensive chemotherapy
Gilead Seeks FDA Approval for Remdesivir
Trials of the drug show that it can cut recovery time from COVID-19 by nearly a third
Longer Bisphosphonate Drug Holiday May Up Fracture Risk
For those with previous vertebral fracture, major osteoporotic fractures increased with holidays >12 months
Short-Term Risk for Below-Knee Amputation Not Increased With SGLT2i
Risk for below-knee amputation not increased versus DPP-4 inhibitor use in patients with type 2 diabetes
Relapse Rates Lower With Ofatumumab in Multiple Sclerosis
Annualized relapse rates lower for ofatumumab versus teriflunomide in two identical phase 3 trials
